Shouhei Tomori¹, Yukiko Nishi¹, Sawako Nakachi¹, Sachie Uchibori¹, Sakiko Kitamura¹, Taeko Hanashiro¹, Natsuki Shimabukuro¹, Keita Tamaki¹, Iori Tedokon¹, Kazuho Morichika¹, Kennosuke Karube², Takuya Fukushima³, Satoko Morishima¹, Hiroaki Masuzaki¹ (1.Second Department of Internal Medicine, Ryukyus Univ., Okinawa, Japan, 2.Department of Pathology and Cell Biology, Ryukyus Univ., Okinawa, Japan, 3.Laboratory of Hematoimmunology, Univ. of the Ryukyus, Okinawa, Japan)

Shigeo Fuji^1,2, Takuhiro Yamaguchi³, Yoshitaka Inoue⁴, Atae Utsunomiya⁵, Yukiyoshi Moriuchi⁶, Satsuki Owatari⁷, Takashi Miyagi⁸, Yasushi Sawayama⁹, Eiichi Ohtsuka¹⁰, Shinichiro Yoshida¹¹, Takahiro Fukuda² (1.Hematology, Osaka International Cancer Institute, Osaka, Japan, 2.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 3.Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan, 4.Hematology, Kumamoto University Hospital, Kumamoto, Japan, 5.Hematology, Imamura General Hospital, Kagoshima, Japan, 6.Hematology, Sasebo City General Hospital, Sasebo, Japan, 7.Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan, 8.Hematology, Heart-Life Hospital, Okinawa, Japan, 9.Hematology, Nagasaki University Hospital, Nagasaki, Japan, 10.Hematology, Oita Prefectural Hospital, Oita, Japan, 11.Hematology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan)

Ki-Ryang Koh¹, Dai Momose¹, Masahiro Manabe¹, Yasuyoshi Sugano¹, Masayuki Hino² (1.Hematol., Osaka General Hospital of West Japan Railway Company, Japan, 2.Hematol., Osaka City University, Osaka, Japan)

Masahito Tokunaga¹, Nobuaki Nakano¹, Tomohisa Tabuchi¹, Jun Odawara¹, Ayumu Kubota¹, Mayumi Tokunaga¹, Kentaro Yonekura², Takayoshi Miyazono¹, Torahiko Makino¹, Shogo Takeuchi¹, Yoshifusa Takatsuka¹, Yoshikiyo Ito¹, Atae Utsunomiya¹ (1.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 2.Department of Dermatology, Imamura General Hospital, Kagoshima, Japan)

Yuma Sakamoto¹, Takashi Ishida^2,3, Ayako Masaki¹, Takayuki Murase¹, Kentaro Yonekura⁴, Yukie Tashiro⁵, Masahito Tokunaga⁶, Atae Utsunomiya⁶, Asahi Ito³, Shigeru Kusumoto³, Shinsuke Iida³, Ryuzo Ueda⁷, Hiroshi Inagaki¹ (1.Dept. Clin. Pathol., Nagoya City Univ., Sch. Med., 2.Hematol & Oncol, Iwate Medical Univ., Sch. Med., 3.Dept. Hematol., Nagoya City Univ., Sch. Med., 4.Dept. Dermatol., Imamura General Hosp., 5.Dept. Pathol., Imamura General Hosp., 6.Dept. Hematol., Imamura General Hosp., 7.Dept. Tumor Immunol, Aichi Medical Univ., Sch. Med.)

Kosuke Toyoda^1,2, Jun-Ichiro Yasunaga², Ilseung Choi³, Youko Suehiro^3,4, Naokuni Uike⁵, Jun Okamura⁶, Masao Matsuoka^1,2 (1.Virus Control, IFLMS, Kyoto University, Kyoto, Japan, 2.Hematology, Rheumatology and Infectious Diseases, Kumamoto University, Kumamoto, Japan, 3.Hematology, National Kyushu Cancer Center, Fukuoka, Japan, 4.Cell Therapy, National Kyushu Cancer Center, Fukuoka, Japan, 5.Palliative Care, Saga-ken Medical Center Koseikan, Saga, Japan, 6.Institute for Clinical Research, National Kyushu Cancer Center, Fukuoka, Japan)